Posts
March 14 2014
pSivida Corp. announced the closing of their Registered Direct offering in the amount of $7,000,000. EG&S acted as counsel to the Placement Agent.
March 13 2014
Galmed Pharmaceuticals Ltd. completed its initial public offering in the amount of $39,700,000. EG&S acted as counsel to the underwriter.
March 13 2014
Anavex Life Sciences Corp. completed a private placement in the amount of $10 million. EG&S acted as counsel to the placement agent.
March 13 2014
University General Health Systems, Inc. announced the closing of their PIPE offering in the amount of $1,232,000. EG&S acted as counsel to the Investor.
March 12 2014
Saul H. Finkelstein, a member of the Firm, was invited to speak at C4CM's audio conference titled "GC Guide to Drafting, Updating & Negotiating Confidentiality Agreements for Corporate Mergers/Acquisitions."
March 07 2014
Mandalay Digital Group, Inc. announced the closing of their Underwritten offering in the amount of $16,273,207. EG&S acted as counsel to the Underwriter.
February 26 2014
Oculus Innovative Sciences, Inc. announced the closing of their Registered Direct offering in the amount of $1,351,860. EG&S acted as counsel to the Placement Agent.
February 24 2014
Benitec Biopharma Limited completed a private placement in the amount of AUD $31.5 million. EG&S acted as counsel to the placement agent.